- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/04 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing only normal peptide links
Patent holdings for IPC class C07K 5/04
Total number of patents in this class: 88
10-year publication summary
|
4
|
3
|
3
|
5
|
5
|
5
|
5
|
7
|
4
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| RS Oncology, LLC | 14 |
5 |
| F. Hoffmann-La Roche AG | 7934 |
2 |
| The Regents of the University of Michigan | 4776 |
2 |
| Ajinomoto Co., Inc. | 2306 |
2 |
| Novozymes A/S | 3335 |
2 |
| Ohio State Innovation Foundation | 2222 |
2 |
| The University of Tokyo | 4247 |
2 |
| viDA Therapeutics Inc. | 15 |
2 |
| Thai Union Group PCL | 40 |
2 |
| École Polytechnique Fédérale de Lausanne (epfl) - Technology Transfer Office (tto) | 3 |
2 |
| Ablevia Biotech GmbH | 26 |
2 |
| Bristol-myers Squibb Company | 4824 |
1 |
| Hoffmann-La Roche Inc. | 3534 |
1 |
| 3m Innovative Properties Company | 17737 |
1 |
| The Regents of the University of California | 20268 |
1 |
| Genentech, Inc. | 4008 |
1 |
| Centre National de La Recherche Scientifique | 10666 |
1 |
| Life Technologies Corporation | 3343 |
1 |
| The Johns Hopkins University | 5752 |
1 |
| Novozymes North America, Inc. | 125 |
1 |
| Other owners | 54 |